Reuters logo
BRIEF-Sanofi's Soliqua 100/33 provided earlier blood sugar control than insulin glargine 100 units/ml
September 12, 2017 / 11:08 AM / in 3 months

BRIEF-Sanofi's Soliqua 100/33 provided earlier blood sugar control than insulin glargine 100 units/ml

Sept 12 (Reuters) - Sanofi Sa:

* Sanofi’s soliqua 100/33 provided earlier blood sugar control than insulin glargine 100 units/ml

* Sanofi - ‍more adults reached HBA(1c) target at 8 and 12 weeks versus those receiving insulin glargine 100 units/ml in trial​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below